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ABSTRACT 
Objectives: South Asians in developed countries like the United Kingdom have 
comparatively high coronary heart disease risk, for reasons which are not fully understood. 
One unexplored hypothesis is more infections in this ethnic group. We assessed whether 
prevalence of infections among South Asians differs from European origin, White populations 
in developed countries. 
Study design: Systematic review. 
Methods: A systematic literature review was carried out using Medline, Web of Science and 
Google Scholar databases. Reference lists and citations were reviewed.  
Results: 21 studies reported prevalence rates and mean antibody levels of infection with 17 
different pathogens or non-specific markers of infection. Among bacterial infections, we 
found higher rates in South Asians for Escherichia coli and Mycobacterium tuberculosis. No 
consistent differences were found for periodontal pathogens, Helicobacter pylori, 
Staphylococcus aureus, Chlamydia pneumoniae and Mycobacterium avium. For viral 
pathogens, higher rates in South Asians were found for hepatitis A, hepatitis B, and 
cytomegalovirus, lower rates for herpes simplex, hepatitis C, human immunodeficiency virus 
and varicella zoster virus, and no difference for hepatitis G virus. Levels of non-specific 
markers of infection (total immunoglobulin G, endotoxin) were higher in South Asians. 
Conclusions: The number of studies was small. We found differences in specific infections, 
but the current evidence is insufficient to support or reject the hypothesis under examination. 
Further studies are warranted.  
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INTRODUCTION 
South Asians − people with ancestral origins in the Indian subcontinent countries of India, 
Pakistan, Bangladesh, Sri Lanka − living in developed countries with White European 
majority populations tend to have a comparatively high mortality risk of coronary heart 
disease (CHD).1-8 Despite considerable research the explanation for this phenomena is not 
completely determined. Although the role of conventional risk factors for atherosclerosis − 
such as tobacco smoking, diabetes mellitus, hyperlipidaemia, hypertension − and the potential 
complex interaction between them - is well recognised, currently these do not fully account 
for the increased risk among South Asians.9-11 Large-scale cohort studies are required to 
assess interactions. Although such studies are currently in progress,12 to date no longitudinal 
data are available in the European setting, specifically for South Asian populations.13 
Novel atherogenic markers have emerged in recent years including chronic systemic 
infections.14,15 The relation between infection and atherosclerosis has been of compelling 
interest but is unclear. In the last decade the most intensively investigated infection has been 
Chlamydia pneumoniae but Helicobacter pylori, cytomegalovirus (CMV), herpes simplex 
virus (HSV), Mycobacterium tuberculosis, influenza and periodontal infections have also 
emerged in this context.14,16-21 A focus on individual infective agents has not yielded 
conclusive results leading to the hypothesis that atherosclerosis might not be specific to one 
organism but to the aggregate “pathogen burden”.22 Several studies have supported this 
hypothesis,23-25 although others did not.26,27 Systemic infections could potentially impact on 
the atherosclerotic process in various ways. Microbes could alter endothelial cell function and 
injure the vessel wall directly, or the infection-induced inflammatory response could have 
pro-atherosclerotic effects through elevated levels of acute phase proteins or through an 
autoimmune mechanism called molecular mimicry.23,24,28 Increased serum level of C-reactive 
protein (CRP) was specifically suggested as an important risk factor for CHD in South 
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Asians.29 However, a recently published mendelian randomisation study did not support this 
hypothesis.30 
 
The pattern of infection in South Asians compared to White European populations has not yet 
been systematically reviewed. Our purpose was to review the literature to see whether 
systemic infections were more common among populations of South Asian ethnic origin than 
among majority ethnic populations in developed countries. The objective was to assess 
whether the infection hypothesis was a serious contender, among the many explanations 
offered by Bhopal,31 in explaining the comparatively high CHD rates in South Asians. 
 
 
METHODS 
Search strategy 
Using the search terms and strategy described in the Appendix 1, Medline, Google Scholar 
and Web of Science database were searched from inception to April 2011. Reference lists 
were studied for additional papers. Personal bibliographic databases of Professor RS Bhopal 
and Dr C Fischbacher were also searched.  
 
Inclusion and exclusion criteria, study selection 
We included original, quantitative, epidemiological studies which described participants with 
ancestral origins in the countries that are now India, Pakistan, Bangladesh and Sri Lanka and 
living in developed countries including countries of the European region, United States, 
Canada, Australia, New Zealand and South Africa. We included only studies that provided 
comparisons with “White Europeans” or the “general population” and which reported 
quantitative measures of markers of systemic infections, focussing on specific infections 
previously associated with CHD, including C. pneumoniae, CMV, H. pylori, HSV, M. 
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tuberculosis, P. gingivalis, influenza or providing measures of total levels of non-specific 
markers of infection such as IgG, total IgA or total IgM. Only English language papers were 
reviewed. 
We excluded studies that examined "Asian" populations without evidence that they were of 
Indian subcontinent origin. We also excluded studies that reported local infections with low 
potential to contributing a generalised atherosclerotic process, such as vulvitis caused by 
Chlamydia trachomatis, urethritis caused by Neisseria gonorrhoeae or bacteruria. 
 
Statistical analysis of the retrieved data 
If statistical analysis was not performed or results were not reported in the study, we 
calculated confidence intervals for proportions and calculated prevalence rate ratios from the 
available data, using Epi Info 3.5.1 software (Centers for Disease Control and Prevention, 
Atlanta, US). Such calculations were marked on the tables with a dagger symbol. As 
statistical power of some studies was low due to small sample size, we have distinguished 
those results where the difference between the two ethnic groups was not statistically 
significant but was equal to or higher than 20%, a difference that we judged as potentially 
important and needs larger studies. 
 
Table 1. 
 
RESULTS 
Methods of reviewed studies 
Twenty-one studies met the inclusion criteria.32-52 Table 1 shows the main features of the 
studies identified. They are categorised according to the infectious agents or markers of 
infection examined and the date of publication. All studies were cross-sectional or reported 
cross-sectional data from case control or cohort designs. Most studies were in the United 
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Kingdom, but we identified papers from Australia,39 South Africa,42 the United States,46 
Italy,47 and New Zealand.50 Only four studies examined randomly selected general population 
samples.36,37,51,52 Other studies were based on schoolchildren,33,34,39,40,44 three-year-old 
children50 or neonates;48 lactating or pregnant women;32,41,45,46,49 hospital patients or clinic 
attendees;35,38,42,43 and volunteers from specific groups like blood donors, immigrants, 
haemodialysis patients or drug users.42,47 Five studies included only women,32,41,45,46,49 one 
only men43 and 10 both genders,35-39,44,47,50-52 while five did not give gender.33,34,39,42,48 The 
indicator of ethnicity was stated in only 13 studies, mostly self reported 
ethnicity37,38,41,43,45,50,51 or country of birth or parents' country of birth,39,47-49,52 or both.44 
Sample size mostly varied from 44 to 1910 for White Europeans and from 9 to 1274 for South 
Asians, excepting one study48 of 340573 blood samples from White European donors and 
45471 samples from South Asians.  
 
Table 2. 
 
Results of reviewed studies 
Table 2 shows there were 15 pathogens studied: seven bacterial32-40 and eight viral agents.41-50 
Two non-specific infectious disease markers were investigated.51,52 Mostly, exposure to 
infection was detected by measuring IgG, IgM or IgA type antibodies with ELISA in blood 
samples, but also IgA antibodies in breast milk;32 IgG in oral fluid samples;44 skin tests;39,40 
identification of pathogens in saliva samples,33 subgingival plaque samples34 or gastric 
biopsies;35 endotoxin measurement in blood samples52 were used. Ten studies adjusted the 
outcome results for potential confounding factors.33,36-38,40,41,46,50-52 In all the adjusted studies 
sex and age were taken into account; four studies also adjusted the results for social 
status,36,37,41,50 and three for cardiovascular risk factors like smoking or blood lipid 
levels.38,51,52 Outcome measures were usually the proportion of participants positive for the 
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examined infection. Only three studies gave average levels of antibody or antigen 
concentration.37,51,52 In one study the mean pathogen (Escherichia coli) specific antibody level 
was compared to the mean total non-specific antibody level.32 
Bacterial infections: Among the seven bacterial pathogens investigated only E. coli32 and M. 
tuberculosis39,40 were consistently more common in South Asians. The difference was 
statistically significant for E. coli and partly significant for M. tuberculosis. The difference 
between the two ethnic groups was negligible (smaller than 20% and showed no statistical 
significance) for C. pneumonia38 and Mycobacterium avium.40 Results were mixed for 
infections with periodontal pathogens,33,34 H. Pylori,35-37 and Staphylococcus aureus:37 for 
periodontal pathogens one study found no difference,33 the other found a significantly higher 
rate in South Asians;34 three studies that compared H. pylori infection gave conflicting results: 
no difference,36 statistically not significant but higher rates in South Asians,35 statistically 
significant lower rates in South Asian females;37 higher antibody levels against S. aureus 
toxin A and toxin B were reported in South Asians but no such difference was seen for toxin 
C and for TSST-1.37 
Viral infections: Eight viral pathogens were investigated from which hepatitis A virus 
(HAV),42-44 hepatitis B virus (HBV),45,46 and CMV50 were more common in South Asians. 
The difference was statistically significant for CMV and HBV but was not consistently 
significant for HAV. HSV,41 hepatitis C virus (HCV),45 human immunodeficiency virus 
(HIV)48 and varicella zoster virus (VZV)49 turned out to be less common in this ethnic group. 
Except the one for HCV, all results were statistically significant. Hepatitis G virus (HGV)47 
showed no difference between the two ethnic groups. 
Non-specific markers of infection: Both total IgG level51 and endotoxin level52 showed 
higher mean levels in South Asians. The differences were statistically significant except when 
the comparison between endotoxin levels were adjusted with metabolic risk factors like blood 
levels of insulin, HDL or triglyceride. 
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Overall: From the 17 specific pathogens and non-specific markers of infection seven found to 
be more common in South Asians (E. coli,32 M. tuberculosis,39,40 HAV,42-44 HBV,45,46 CMV,50 
total IgG level,51 endotoxin level52). The difference was statistically significant in four (E. 
coli,32 HBV,45,46 CMV,50 total IgG level51). Four pathogens were less common in South 
Asians (three statistically significant differences: HSV,41 HIV,48 VZV49 and one not 
significant: HCV45). Three pathogens showed no difference (C. Pneumonia,38 M. avium,40 
HGV47), and three gave mixed results (periodontal pathogens,33,34 H. pylori,35-37, S. aureus37). 
 
 
DISCUSSION 
Overview of key findings 
Overall, this review indicates differences for certain specific infections between South Asians 
and White Europeans in developed countries. Among the pathogens associated with 
atherosclerosis there was consistent evidence that M. tuberculosis and CMV infection were 
more common in South Asians.39,40,50 However, HSV was less common in this ethnic group.41 
There was no consistent evidence of differences in the prevalence of infection with C. 
pneumoniae, H. pylori, or periodontal pathogen infections.33-38 Among infectious agents or 
infectious markers that have not been previously linked with CHD, E. coli, HAV, HBV, total 
IgG and endotoxin level were more common,32,42,43-46,51 and HIV, VZV and HCV less 
common in South Asians.45,48,49 For a further three pathogens clear ethnic differences were 
not found. 
 
Limitations and strengths  
We found only five pathogens that were investigated by more than one study (periodontal 
pathogens,33,34 H. pylori,35-37 M. tuberculosis,39,40 HAV,42-44 HBV45,46) and for the other 12 
infectious agents or markers of infection one single study was found for each. This, as well as 
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the significant heterogeneity in study populations, differences in indicator of infection and 
often low sample size, made the interpretation difficult. Recent studies have confirmed the 
inverse association between infectious burden and socioeconomic and educational status.53,54 
Furthermore the greater pathogen burden in developing countries is well known. These 
findings make it necessary to take into account social class, educational level and the time that 
a person spent in developing countries when interpreting data. 
We found only four studies37,38,41,51 which had relatively high participation rate (i.e.: more 
than 100 subjects in each ethnic groups) and also adjusted the results for social class and/or 
cardiovascular risk factors. However, even if the analysis is restricted to these higher quality 
studies, the differences between the two ethnic groups in overall infectious rates remained 
inconsistent. (H. pylori, S. aureus giving mixed results;37 C. pneumonia showing no 
difference;38 HSV showing lower rate in South Asians;41 and total IgG showing higher rates 
in South Asians51) 
 
We summarised the differences in individual infectious rates between South Asians and 
White Europeans. Evidence on the cumulative pathogen burden was limited as studies 
examined only one or two pathogens. Hence, only the two studies that reported data on non-
specific markers of infection51,52 measured, indirectly, some levels of actual cumulative 
pathogen burden. 
 
Conclusion 
Our systematic review provided evidence of ethnic differences in some specific infections, 
but no clear support for the overall burden of infection hypothesis. From the individual 
pathogens which might contribute to the evolution of atherosclerosis M. tuberculosis and 
CMV were reported to be more common in South Asians. The small number and 
methodological weaknesses of the relevant studies limit our conclusions. Further studies with 
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appropriate control of potential confounders are needed to clarify the role of these specific 
pathogens. 
 
To pursue the question we would need to measure prevalence rates of all the potentially 
relevant pathogens in representative population samples in each of the ethnic groups of 
interest. Such research has been already carried out on other ethnic groups,55 and a study of 
South Asians is required. A multi-ethnic cohort study with repeatedly collected data on 
pathogen burden would provide even stronger evidence. Until these studies are done, the 
question posed by the systematic review remains open. 
 
More sound understanding of the factors which contribute to the high CHD risk of South 
Asians would allow more specific and focused public health interventions in this ethnic 
group. If infection plays a role, it imposes a double disease burden on affected individuals and 
preventive measures would be particularly important. In light of these, the answer for the 
question could have relevant public health implications in the future. 
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Table 1.: Contextual details of the studies on bacterial infections (A), viral infections (B) and non-specific markers of infection (C): 
publication, time and location of the study, sample selection, sex and age distribution of study populations, sample size 
 
A. Bacterial infections 
Study  
(First author, date of 
publication, examined 
pathogen or indicator of 
infection, reference) 
a.Date of fieldwork,           
b.Place,                                
c.Basis of sample 
% females Mean age in years  Inclusion criteria Indicator of 
ethnicity 
Response 
rate 
Sample size 
Nathavitharana KA, 
1994  
Escherichia coli 
[32]  
a.Not stated                                 
b.Birmingham, UK        
c.Volunteer lactating   
   women 
 100%  W: 29 (r: 20-39) 
SA: 26 (r: 20-37) 
Lactating women Not stated Not stated  W:  75  
SA:  20 
Drucker DB, 1995 
Periodontal pathogens 
[33] 
a.Not stated                          
b.Keighley, UK 
c.Targeted sample of  
   schoolchildren 
Not 
specified 
   5 Children who had teeth with 
obvious carious lesions 
Not stated Not stated  W:  70  
SA:  70 
Elwood R, 1997 
Periodontal pathogens 
[34] 
a.Not stated                        
b.Manchester, UK                    
c.Targeted sample of  
   schoolchildren 
Not 
specified 
  13 (SD: 0.33) Children had to have both 
upper first permanent molars 
present, no history of 
rheumatic fever, jaundice, 
hepatitis, heart disease or be 
taking antibiotics 
Not stated Not stated  W: 333  
SA: 187 
Seery JP, 1997 
Helicobacter pylori  
[35] 
a.Not stated                                 
b.Southall, UK             
c.Consecutive hospital  
   patients 
 W: 41% 
SA: 46% 
 W: 47   
SA: 45 
Not stated Not stated Not stated  W: 107  
SA: 124 
Stone MA, 1998 
Helicobacter pylori 
[36] 
a.Not stated                              
b.Leicester, UK              
c.Randomly selected  
   subjects in one GP   
   district 
 W: 56% 
SA: 54% 
 W: 44   
SA: 40 
People between 21-55 years Not stated  W: 22.6% 
SA: 28% 
 W:   44  
SA: 112 
Fischbacher CM, 2004 
Helicobacter pylori, 
Staphylococcus aureus 
[37] 
 
Continued 
a.W: Apr 1993 – Oct 1994 
   SA: May 1995 – March 1997 
b.Newcastle upon Tyne, UK   
c.Randomly selected subjects  
   from the Newcastle Heart  
   Project (NHP) 
 W: 52% 
SA: 54% 
 W: 54 (SD: 13)  
SA: 50 (SD: 12) 
People between 25-74 years Self reporting:   
W: ancestral origin 
in Europe                        
SA: 3 or more grand 
parents from the 
Indian Subcontinent                   
NHP:  
 W: 67.5% 
SA: 64.2% 
 W: 302  
SA: 300 
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Study  
(First author, date of 
publication, examined 
pathogen or indicator of 
infection, reference) 
a.Date of fieldwork,           
b.Place,                                
c.Basis of sample 
% females Mean age in years  Inclusion criteria Indicator of 
ethnicity 
Response 
rate 
Sample size 
Cook PJ, 1998 
Chlamydia pneumoniae  
[38] 
a. Jan 1993 – Jan 1995                      
b.Birmingham, UK                        
c.Randomly selected hospital    
   patients 
W: 43% 
SA: 48% 
 W: 60 (SD: 17.4) 
SA: 49 (SD: 17.3) 
No evidence of active cardiac, 
vascular, pulmonary disease; 
No known/suspected 
immuno-deficiency, 
autoimmun disease, hyper-
gammaglobulinaemia 
Self reporting   96%  W:1061  
SA:  290 
Johnson PDR, 1998 
Mycobacterium 
tuberculosis 
[39] 
a. 1995                    
b.Melbourne, Australia   
c.Partly random and partly  
   targeted sample of  
   schoolchildren 
Not 
specified 
   r: 9-10 Not stated Country of birth  49%  W: 156  
SA: 114 
Weir RE, 2003 
Mycobacterium 
tuberculosis, 
Mycobacterium avium  
[40] 
a.Feb 1999 – Apr 2000                                      
b.Southeast England, UK 
c.Volunteer schoolchildren 
  49%   13 (r: 12-15) No record of BCG 
vaccination or any serious or 
immunmodulatory disease 
Not stated Not stated  W: 321  
SA:  32 
 
B. Viral infections 
Ades AE, 1989  
Herpes Simplex Virus 
(HSV)  
[41] 
a.1980–1981                              
b.London, UK             
c.Consecutive pregnant women  
   attending antenatal clinics 
 100% Not specified Not stated Self identification Not stated  W:1226  
SA:  742  
Sathar MA, 1994 
Hepatitis A Virus (HAV)  
[42] 
a.Not stated                           
b.Durban, South Africa  
c.Randomly selected hospital  
   patients, outpatient attendees,  
   volunteer blood donors 
Not 
specified 
 W: r: 17-87 
SA: r: 17-84 
Not stated Not stated Not stated  W: 187  
SA: 163 
Ross JDC, 2002 
Hepatitis A Virus (HAV)  
[43] 
 
Continued 
a.Not stated                         
b.Birmingham, UK 
c.Consecutive outpatient   
   facility attendees 
   0% Not specified Age over 16 years, not 
received normal immun-
globulin in the last 12 months, 
not vaccinated against HAV, 
not infected with HIV 
Self identification Not stated  W: 146  
SA:     9 
 21 
Study  
(First author, date of 
publication, examined 
pathogen or indicator of 
infection, reference) 
a.Date of fieldwork,           
b.Place,                              
c.Basis of sample 
% females Mean age in years 
 
Inclusion criteria Indicator of 
ethnicity 
Response 
rate 
Sample size 
Morris-Cunnington M, 
2004  
Hepatitis A Virus (HAV)  
[44] 
a.Not stated                              
b.Northwestern England, UK         
c.Volunteer schoolchildren 
  52%   R: 7-12 Not stated Self identification of 
parent / Participant's 
country of birth / 
Parents' country of 
birth 
 20.9%  W:   74  
SA: 153 
Boxall E, 1994  
Hepatitis B Virus (HBV)  
Hepatitis C Virus (HCV)  
[45] 
a.Not stated                       
b.Birmingham, UK                   
c.Consecutive pregnant women  
   attending an antenatal clinic 
 100% Not specified Not stated Self identification Not stated  W:1604 
SA:1274 
Euler GL, 2003 
Hepatitis B Virus (HBV)  
[46] 
a.1990–1993                                           
b.Four states (CT, GA, MI,   
   TX) in the US                          
c.Randomly selected pregnant  
   Women 
100% Not specified Not stated Self identification Not stated  W:1910  
SA:  366 
Villari P, 2001  
Hepatitis G Virus (HGV)  
[47] 
 
a.1998                                 
b.Lazio, Italy                         
c.Volunteer blood donors,    
   drug users, hemodialysis  
   patients, immigrants 
 W: 18% 
SA: Not 
       stated 
Not specified Not stated   Country of origin Not stated  W: 357  
SA:   79 
Cortina-Borja M, 2004  
Human Immuno-
deficiency Virus (HIV) 
[48] 
a.1998–2002                           
b.London, UK                    
c.Neonatal babies  
Not 
specified 
Not specified Not stated Place of mother's 
birth 
Not stated  W:340,573 
SA:  45,471 
Talukder YS, 2007  
Varicella Zooster Virus 
(VZV) 
[49] 
a. Oct 2001 – March 2002 
    Sept 2003 – Febr 2004                         
b.London, UK            
c.Consecutive pregnant women  
   attending an antenatal clinic 
 100%  W: 28 (SD: 6.4)  
SA: 26 (SD: 5) 
Only British and Bangladeshi 
women were included 
Place of birth / 
Place of parents' 
birth 
 92%  W: 275  
SA: 765 
O'Brien TP, 2009 
Cytomegalo-virus (CMV) 
[50] 
 
Continued 
a.Apr 1998 – May 2001                                
b.Auckland, New Zealand 
c.Randomly selected children  
   from Auckland Birthweight  
   Collaborative Study (ABCS) 
  51%    3.5 All babies were born at 37 or 
more completed weeks of 
gestation 
Self reported by the 
mother 
 W: 63.2% 
SA: 29% 
 W: 409  
SA:  29 
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Study  
(First author, date of 
publication, examined 
pathogen or indicator of 
infection, reference) 
a.Date of fieldwork,           
b.Place,                              
c.Basis of sample 
% females Mean age in years 
 
Inclusion criteria Indicator of 
ethnicity 
Response 
rate 
Sample size 
C. Non-specific markers of infection 
Fischbacher CM, 2003  
Total IgG level 
[51] 
a. W: Apr 1993 – Oct 1994 
   SA: May 1995 – March 1997                                                                          
b.Newcastle upon Tyne,UK       
c.Randomly selected subjects      
   from the Newcastle Heart  
   Project (NHP) 
 W: 52% 
SA: 54% 
 W: 54 (SD: 13)  
SA: 50 (SD: 12)
People between 25-74 years Self reporting: 
W:ancestral origin 
in Europe                        
SA:3 or more 
grand parents were 
born in the Indian 
Subcontinent                   
NHP: 
 W: 67.5% 
SA: 64.2% 
 W: 302  
SA: 300 
Miller MA, 2009 
Endotoxin level  
[52] 
a. 1994 – 1996                                    
b.London,UK            
c.Randomly selected subjects  
   from the Wandsworth Heart    
   and Stroke Study (WHSS) 
W: 49% 
SA: 52% 
Not specified age 40-59; no antihypertensive 
or lipid lowering medication; 
no oral anticoncipient or 
hormone replacement therapy; 
no diabetes; no previous CHD 
or stroke 
WHSS: Subject's 
and their parent's 
place of birth  
WHSS: 
 64% 
 W:  61  
SA:  63 
W, White European; SA, South Asian 
 r, Range; SD, Standard Deviation 
CT, Connecticut; GA, Georgia; MI, Michigan; TX, Texas 
NHP, Newcastle Heart Project; ABCS, Auckland Birthweight Collaborative Study; WHSS, Wandsworth Heart and Stroke Study 
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Table 2.: Findings and analysis of the studies on bacterial infections (A), viral infections (B) and non-specific markers of infection (C): compared 
indicator of infection, adjustment, percentage of positive cases or means of antibody levels in study populations, statistical analysis and overall 
summary of the results ( † indicates additional analysis by authors) 
 
A. Bacterial infections 
Study Compared indicator of infection Adjustment Percentage of positive cases (%) 
or means of antibody levels (m) 
in study populations (95% CI) 
Statistical analysis Summary 
Infectious rate in South Asians 
vs. White Europeans 
Nathavitharana 
KA et al. 
(1994) [32] 
Escherichia coli:  
Mean E. coli specific secretory IgA 
level in breast milk (as a percentage of 
total non-specific secretory IgA level) 
None (m)  W:   0.7 
SA:   4.0 
p<0.001  Higher 
Statistically significant 
Difference ≥20% 
Drucker DB et 
al. (1995) [33] 
Streptococcus mutans:  
Proportion of cases with over 103cfu 
counts/ml (in saliva samples) 
Age, sex, number of 
unrestored decayed    
dental surfaces 
(%)  W: 85.7 (77.5-93.9) † 
SA: 90.0 (83.0-97.0) † 
PRR=1.05 (0.93-1.17) † No difference 
Statistically not significant  
Difference <20% 
Lactobacillus:  
Proportion of cases with over 103cfu 
counts/ml (in saliva samples) 
Age, sex, number of 
unrestored decayed    
dental surfaces 
(%)  W: 51.4 (39.7-63.1) † 
SA: 50.0 (38.3-61.7) † 
PRR=0.97 (0.70-1.35) † No difference 
Statistically not significant 
Difference <20% 
Elwood R et al. 
(1997) [34] 
Periodontal pathogens:  
Proportion of cases with detected 
pathogens (in subgingival plaques) 
None (%)  W:   9.0  ( 5.9-12.1) † 
SA: 22.4 (16.5-28.4) † 
PRR=2.49 (1.63-3.80) † Higher  
Statistically significant 
Difference ≥20% 
Seery JP et al. 
(1997) [35] 
Helicobacter pylori:  
Proportion of positive cases  
(in gastric biopsies) 
None (%)  W: 43.0 (33.6-52.4) † 
SA: 52.0 (43.2-60.7) † 
PRR=1.20 (0.91-1.59) † Higher 
Statistically not significant  
Difference ≥20% 
Stone MA et al. 
(1998) [36] 
Helicobacter pylori:  
Proportion of seropositive cases 
Age, sex, social class (%)  W: 47.0 (32.3-61.8) † 
SA: 53.0 (43.8-62.2) † 
PRR=0.83 (0.56-1.19) † 
 
No difference 
Statistically not significant 
Difference <20% 
Fischbacher 
CM et al. 
(2004) [37] 
 
 
 
 
Continued 
Helicobacter pylori: 
Mean IgG level in blood samples 
(μg/ml) 
Age, social 
class, income, 
education 
men 
 
(m)  W: 16.7 (13.9-20.2) 
SA: 11.6  ( 9.8-13.7) 
  OR=0.73 (0.55-0.96) Lower 
Statistically significant 
Difference ≥20% 
women (m)  W: 11.3  ( 9.4-13.5) 
SA: 14.3 (12.1-16.9) 
  OR=1.23 (0.89-1.70) Higher 
Statistically not significant  
Difference ≥20% 
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Study Compared indicator of infection Adjustment Percentage of positive cases (%) 
or means of antibody levels (m) 
in study populations (95% CI) 
Statistical analysis Summary 
Infectious rate in South Asians 
vs. White Europeans 
Fischbacher 
CM et al. 
(2004) [37] 
(cont.) 
Staphylococcus aureus:  
Mean IgG level against toxin A in 
blood samples (μg/ml) 
None men (m)  W:   3.6  ( 3.2-4.2) 
SA:   5.5  ( 5.6-6.7) 
p<0.05 † Higher  
Statistically significant 
Difference ≥20% 
women (m)  W:   3.4  ( 3.0-3.9) 
SA:   4.8  ( 4.1-5.7) 
p<0.05 † Higher  
Statistically significant 
Difference ≥20% 
Staphylococcus aureus:  
Mean IgG level against toxin B in 
blood samples (μg/ml) 
None men (m)  W: 10.6  ( 9.1-12.3) 
SA: 22.9 (19.0-27.5) 
p<0.05 † Higher  
Statistically significant 
Difference ≥20% 
women (m)  W: 12.4 (10.8-14.2) 
SA: 19.8 (16.7-23.4) 
p<0.05 † Higher  
Statistically significant 
Difference ≥20% 
Staphylococcus aureus: 
Mean IgG level against toxin C in 
blood samples (μg/ml) 
None  men (m)  W: 19.6 (16.8-23.0) 
SA: 27.0 (22.9-31.7) 
p>0.05 † Higher 
Statistically not significant 
Difference ≥20% 
women (m)  W: 22.3 (19.5-25.7) 
SA: 23.6 (20.2-27.7) 
p>0.05 † No difference 
Statistically not significant 
Difference <20% 
Staphylococcus aureus:  
Mean IgG level against TSST-1 in 
blood samples (μg/ml) 
None men (m)  W:   8.8  ( 7.6-10.1) 
SA:   9.2  ( 7.7-10.9) 
p>0.05 † No difference 
Statistically not significant 
Difference <20% 
women (m)  W: 10.1  ( 8.8-11.5) 
SA:   9.0  ( 7.8-10.5) 
p>0.05 † No difference 
Statistically not significant 
Difference <20% 
Cook PJ et al. 
(1998) [38] 
Chlamydia pneumoniae:  
Proportion of seropositive cases 
Age, sex, smoking habit, 
date of admission 
(%)  W: 16.6 (14.4-18.8) † 
SA: 18.9 (14.5-23.5) † 
PRR=1.14 (0.88-1.52) † No difference 
Statistically not significant 
Difference <20% 
Johnson PDR et 
al. (1998) [39] 
 
 
Continued 
Mycobacterium tuberculosis: 
Proportion of cases with positive 
Mantoux tests 
None (%)  W:   0.6  (-0.6-1.9) † 
SA:   2.7  (-0.3-5.6) † 
PRR=4.10 (0.59-28.59) † Higher 
Statistically not significant  
Difference ≥20% 
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Study Compared indicator of infection Adjustment Percentage of positive cases (%) 
or means of antibody levels (m) 
in study populations (95% CI) 
Statistical analysis Summary 
Infectious rate in South Asians 
vs. White Europeans 
Weir RE et al. 
(2003) [40] 
Mycobacterium tuberculosis: 
Proportion of participants with a 
positive tuberculin test  
Age, sex, attended school (%)  W: 16.0 (12.0-20.0) † 
SA: 41.0 (24.0-58.0) † 
PRR=2.56 (1.52-3.93) † Higher 
Statistically significant 
Difference ≥20% 
 
Mycobacterium tuberculosis: 
Proportion of participants with 
positive in vitro IFNγ response to PPD 
Age, sex, attended school (%)  W: 22.0 (17.5-26.5) † 
SA: 47.0 (29.7-64.9) † 
PRR=2.12 (1.34-3.04) † Higher 
Statistically significant 
Difference ≥20% 
 Mycobacterium avium:  
Proportion of participants with 
positive in vitro IFNγ response to PPD 
Age, sex, attended school (%)  W: 59.0 (53.6-64.4) † 
SA: 58.0 (40.9-75.1) † 
PRR=1.01 (0.71-1.29) † No difference 
Statistically not significant 
Difference <20% 
B. Viral infections 
Ades AE et al 
(1989) [41] 
Herpes Simplex Virus (HSV-1): 
Proportion of seropositive cases  
Age, marital status, social 
class 
(%)  W: 80.1 (77.9-82.3) † 
SA: 72.5 (69.3-75.7) † 
PRR=0.91 (0.86-0.96) † Lower 
Statistically significant 
Difference <20% 
Herpes Simplex Virus (HSV-2): 
Proportion of seropositive cases 
Age, marital status, social 
class 
(%) 
 W:   7.2  ( 5.7-8.6) † 
SA:   3.4  ( 2.1-4.7) † 
PRR=0.47 (0.30-0.72) † Lower 
Statistically significant 
Difference ≥20% 
Sathar MA et 
al. (1994) [42] 
Hepatitis A Virus (HAV):  
Proportion of seropositive cases  
None (%)  W: 50.0 (42.8-57.2) † 
SA: 67.0 (59.8-74.2) † 
PRR=1.33 (1.11-1.58) † Higher 
Statistically significant 
Difference ≥20% 
Ross JDC, et al. 
(2002) [43] 
Hepatitis A Virus (HAV):  
Proportion of seropositive cases 
None (%)  W: 21.0 (14.4-27.6) † 
SA: 56.0 (23.6-88.4) † 
PRR=2.62 (1.19-4.10) † Higher 
Statistically significant 
Difference ≥20% 
Morris-
Cunnington M, 
et al. (2004) 
[44] 
 
 
 
 
 
 
 
 
Continued 
Hepatitis A Virus (HAV):  
Proportion of seropositive cases  
  (from oral fluid samples) 
None 
 
In
d
ic
at
o
r 
o
f 
et
h
n
ic
it
y
 
parental self 
identification 
 
(%)  W: 13.2  ( 5.0-21.3) 
SA: 21.3 (14.8-27.7) 
PRR=1.60 (0.86-3.08) † Higher 
Statistically not significant 
Difference ≥20% 
subject's 
country of birth 
 
(%)  W: 17.3 (12.2-22.5) 
SA: 54.1 (23.3-84.9) 
PRR=3.09 (1.92-5.20) † Higher 
Statistically significant 
Difference ≥20% 
mother's 
country of birth 
 
(%)  W: 14.3  ( 7.0-21.7) 
SA: 22.8 (15.5-30.2) 
PRR=1.54 (0.85-2.88) † Higher 
Statistically not significant 
Difference ≥20% 
father's country 
of birth 
(%)  W: 13.7  ( 5.7-21.7) 
SA: 21.8 (15.0-28.5) 
PRR=1.60 (0.86-3.08) † Higher 
Statistically not significant 
Difference ≥20% 
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Study Compared indicator of infection Adjustment Percentage of positive cases (%) 
or means of antibody levels (m) 
in study populations (95% CI) 
Statistical analysis Summary 
Infectious rate in South Asians 
vs. White Europeans 
Boxall E, et al. 
(1994) [45] 
Hepatitis C Virus (HCV): 
Proportion of seropositive cases 
None (%)  W:   0.25 ( 0.01-0.49) † 
SA:   0.08 (-0.08-0.24) † 
PRR=0.32 (0.05-2.10) † Lower 
Statistically not significant 
Difference ≥20% 
Hepatitis B Virus (HBV): 
Proportion of seropositive cases  
None (%)  W:   0.0 (-0.4-0.4) † 
SA:   1.04 ( 0.47-1.57) † 
PRR=infinite † Higher 
Statistically significant 
Difference ≥20% 
Euler GL et al 
(2003) [46] 
Hepatitis B Virus (HBV): 
Proportion of seropositive cases 
(95%CI) 
Prenatal care, source of 
pay, age, year of infant's 
birth 
(%)  W:   0.6  ( 0.3-1.1) 
SA:   3.2  ( 0.8-8.7) 
PRR=5.69 (2.58-12.55) † Higher 
Statistically significant 
Difference ≥20% 
Villari P, et al. 
(2001) [47] 
Hepatitis G Virus (HGV): 
Proportion of seropositive cases  
None (%)  W: 12.6  ( 9.2-16.1) † 
SA: 12.7  ( 5.3-20.0) † 
PRR=1.01 (0.53-1.85) † No difference 
Statistically not significant 
Difference <20% 
Cortina-Borja M 
et al. (2004) [48] 
Human Immunodeficiency Virus 
(HIV):  
Proportion of seropositive cases  
None (%)  W:   0.04 ( 0.03-0.05) † 
SA:   0.02 ( 0.01-0.03) † 
PRR=0.50 (0.25-0.96) † Lower 
Statistically significant 
Difference ≥20% 
Talukder YS, et 
al. (2007) [49] 
Varicella Zooster Virus (VZV): 
Proportion of seropositive cases  
None (%)  W: 93.6 (90.5-96.4) † 
SA: 85.7 (83.3-88.2) † 
PRR=0.92 (0.89-0.96) † Lower 
Statistically significant 
Difference <20% 
O'Brien et al. 
(2009) [50] 
 
 
 
 
Continued 
Cytomegalovirus (CMV): 
Proportion of seropositive cases 
Sex, day care attendance, 
breastfeeding duration, 
mother's age, occupation, 
marital status, education, 
number of people in the 
household 
(%)  W: 26.5 (22.1-30.7) † 
SA: 50.0 (31.8-68.2) † 
PRR=1.96 (1.27-2.70) † Higher 
Statistically significant 
Difference ≥20% 
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Study Compared indicator of infection  Adjustment Percentage of positive cases (%) 
or means of antibody levels (m) 
in study populations (95% CI) 
Statistical analysis Summary  
Infectious rate in South Asians 
vs. White Europeans 
C. Non-specific markers of infection 
Fischbacher CM 
et al. (2003) [51] 
Total IgG level:  
Mean in blood samples (g/L) 
Age, sex, smoking status (m)  W:   7.4  ( 6.7 - 8.2) 
SA: 13.5 (12.1-15.2) 
  OR=1.75 (1.48-2.08) Higher 
Statistically significant  
Difference ≥20% 
Miller MA et al. 
(2009) [52] 
Endotoxin level:  
Geometric mean in blood samples 
(Eu/mL) 
age, sex 
total cholesterol level 
 
insulin level 
HDL level 
triglyceride level 
(m)  W: 10.9  ( 9.8-12.1) 
SA: 13.3 (12.0-14.7) 
p=0.013 
p=0.001 
Higher 
Statistically significant 
Difference ≥20% 
p=0.371 
p=0.321 
p=0.411  
Higher 
Statistically not significant 
Difference ≥20% 
W, White European; SA, South Asian,  
CI, Confidence Interval; OR, Odds Ratio; PRR, Prevalence Rate Ratio  
cfu, Colony Forming Unit 
† additional analysis by author 
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Appendix 1 (search strategies)  
Search strategy for Medline (Compiled after consultation with librarian: Marshall Dozier, University of 
Edinburgh): 
south asia*, asian india*, india*, pakistan*, bangladesh*, sri lanka*, exp Ethnic Groups/ AND exp "bacterial 
infections and mycoses"/, exp Parasitic Diseases/, exp Virus Diseases/, pathogen burden*, exp 
Cytomegalovirus Infections/, exp Chlamydia Infections/, cmv, exp Helicobacter Infections/, hsv, exp Herpes 
Simplex/, exp Mycobacterium tuberculosis/, exp Periodontitis/, exp Gingivitis/, exp Porphyromonas 
gingivalis/, exp Influenza, Human/, exp Immunoglobulin G/, exp Immunoglobulin M/, exp Immunoglobulin 
A/, AND exp North America/, exp Europe/, exp Australia/, AND exp Epidemiologic Methods/, exp 
comparative study/, NOT exp American Native Continental Ancestry Group/ 
 
Search strategy for Web of Science  
south asia* or asian india* or india* or pakistan* or bangladesh* or sri lanka* or ethnic* AND infection* 
AND epidemiologic study* or comparative study* or case control* or cohort* or cross sectional* or 
seroepidemiology* or seroprevalence* 
 
Search strategy for GoogleScholar:  
- with all of the words: infection, ethnic groups 
- with at least one of the words: south asia* or asian india* or india* or pakistan* or    
    bangladesh* or sri lanka*  
- without the words: "american indian"  
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Appendix 2 (quorum diagram) 
All results of electronic
database search: 
N=4883 
Articles excluded by title, abstract
and duplicate search:
N=4771
Potential relevant articles: 
N=112
Articles excluded due to the following reasons (N= 91):
• Reports ethnic variation among patients who
were diagnosed with infectious disease
(case series): 
N=31
• Examines "Asian" populations without evidence
that they were of Indian subcontinent origins: 
N=22
• Describes South Asian population without White
European comparison group: 
N=13
• Describes South Asians who live in South Asia: 
N=11
• Reports local infections with low potential to
contributing a generalised atherosclerotic
process: 
N=9
• Reports no indicator of infection: 
N=5
Articles included in the
review:
N=21
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Appendix 3 (list of relevant but excluded papers) 
Examines "Asian" populations without evidence that they were of Indian subcontinent origins: 
▪ Badami KG, et al. Cytomegalovirus seroprevalence and 'cytomegalovirus-safe' seropositive blood 
donors. Epidemiol Infect. 2009;137:1776-80. 
▪ Zajacova A, Dowd JB, Aiello AE.: Socioeconomic and race/ethnic patterns in persistent infection 
burden among U.S. adults. J Geront A Biol Sci Med Sci. 2009;64:272-9.  
▪ Tindberg Y, et al. The accuracy of serologic diagnosis of Helicobacter pylori infection in school-
aged children of mixed ethnicity. Helicobacter. 2001;6:24-30. 
▪ Verdú EF, et al. Prevalence of Helicobacter pylori infection and chronic dyspeptic symptoms among 
immigrants from developing countries and people born in industrialized countries. Digestion. 
1996;57:180-5. 
 
Reports local infections with low potential to contributing a generalised atherosclerotic process:  
▪ Tariq S, et al. Sexual health services for South Asians in London, UK: a case-control study. Int J 
STD AIDS. 2007;18:563-4. 
▪ Versi E, et al. Bacteriuria in pregnancy: a comparison of Bangladeshi and Caucasian women. Int 
Urogynecol J Pelvic Floor Dysfunct. 1997;8:8-12. 
▪ Skinner CJ, Saulsbury NK, Goh BT. Sexually transmitted infections in Bangladeshis resident in the 
UK: a case-control study. Sex Transm Infect. 2002;78:120-2. 
▪ Simms I, et al. The English National Chlamydia Screening Programme: variations in positivity in 
2007/2008. Sex Transm Dis. 2009;36:522-7. 
▪ Fenton KA, et al. Ethnic variations in sexual behaviour in Great Britain and risk of sexually 
transmitted infections: a probability survey. Lancet. 2005;365:1246-55. 
 
 
